Evidence map›Paper›PMID 22558422›Full record

ArticlePloS one2012

FcRn overexpression in transgenic mice results in augmented APC activity and robust immune response with increased diversity of induced antibodies.

Attila Végh, Anita Farkas, Dorottya Kövesdi, Krisztián Papp, Judit Cervenak, Zita Schneider, Balázs Bender, László Hiripi, Glória László, József Prechl and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Rhesus Macaques: VNTR Polymorphism of the FCGRT Gene.Bulletin of experimental biology and medicine · 2024
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Targeting FcRn to Generate Antibody-Based Therapeutics.Trends in pharmacological sciences · 2018
    Review
  11. Article
  12. Distribution of FcRn Across Species and Tissues.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2017
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Genetically engineered humanized mouse models for preclinical antibody studies.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2014
    Review
  18. The Role of FcRn in Antigen Presentation.Frontiers in immunology · 2014
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Attila VéghImmunoGenes Kft, Budakeszi, Hungary.
Anita Farkas
Dorottya Kövesdi
Krisztián Papp
Judit Cervenak
Zita Schneider
Balázs Bender
László Hiripi
Glória László
József Prechl
János Matkó
Imre Kacskovics
Eötvös Loránd University · HUImmunoGenes (Hungary) · HUAgricultural Biotechnology Institute · HUHungarian Academy of Sciences · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our previous studies have shown that overexpression of bovine FcRn (bFcRn) in transgenic (Tg) mice leads to an increase in the humoral immune response, characterized by larger numbers of Ag-specific B cells and other immune cells in secondary lymphoid organs and higher levels of circulating Ag-specific antibodies (Abs). To gain additional insights into the mechanisms underlying this increase in humoral immune response, we further characterized the bFcRn Tg mice. Our Western blot analysis showed strong expression of the bFcRn transgene in peritoneal macrophages and bone marrow derived dendritic cells; and a quantitative PCR analysis demonstrated that the expression ratios of the bFcRn to mFcRn were 2.6- and 10-fold in these cells, respectively. We also found that overexpression of bFcRn enhances the phagocytosis of Ag-IgG immune complexes (ICs) by both macrophages and dendritic cells and significantly improves Ag presentation by dendritic cells. Finally, we determined that immunized bFcRn mice produce a much greater diversity of Ag-specific IgM, whereas only the levels, but not the diversity, of IgG is increased by overexpression of bFcRn. We suggest that the increase in diversity of IgG in Tg mice is prevented by a selective bias towards immunodominant epitopes of ovalbumin, which was used in this study as a model antigen. These results are also in line with our previous reports describing a substantial increase in the levels of Ag-specific IgG in FcRn Tg mice immunized with Ags that are weakly immunogenic and, therefore, not affected by immunodominance.

Indexed as

Amino Acid SequenceAnimalsAntibodies, MonoclonalAntibody SpecificityAntigen PresentationAntigen-Presenting CellsBone Marrow CellsCattleDendritic CellsEpitopesFemaleGene ExpressionHistocompatibility Antigens Class IImmunoglobulin GImmunoglobulin MMacrophages, PeritonealAntibodies, MonoclonalEpitopesFc receptor, neonatalHistocompatibility Antigens Class IImmunoglobulin GImmunoglobulin MOvalbuminReceptors, Fc

Identifiers

PMID22558422
PMCPMC3340356
OpenAlexW2028937768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.